XML 35 R13.htm IDEA: XBRL DOCUMENT
v3.25.3

Earnings Per Share and Certain Related Information | 12 Months Ended
--- | ---
Sep. 26, 2025
Earnings Per Share Reconciliation [Abstract] |
Earnings Per Share and Certain Related Information | Earnings Per Share and Certain Related Information Basic and Diluted Earnings Per Share Basic and diluted earnings per share (“EPS”) are computed using the two-class method, which is an earnings allocation method that determines EPS for common shares and participating securities. The undistributed earnings are allocated between common shares and participating securities as if all earnings had been distributed during the period. Participating securities and common shares have equal rights to undistributed earnings. Net earnings used for the purpose of determining basic and diluted EPS is determined by taking net earnings, less earnings available to participating securities and the redeemable noncontrolling interests redemption value adjustment associated with the PA Consulting investment. The following table reconciles the numerator and denominator used to compute basic EPS to the denominator used to compute diluted EPS for the years ended September 26, 2025, September 27, 2024 and September 29, 2023 (in thousands):
| For the Years Ended
| September 26, 2025 |  | September 27, 2024 |  | September 29, 2023
Numerator for Basic and Diluted EPS: |  |  |  |  |
Net earnings attributable to Jacobs from continuing operations | $ | 313,302 |  |  | $ | 612,804 |  |  | $ | 379,125 |
Redeemable Noncontrolling interests redemption value adjustment (See Note 15- PA Consulting Redeemable Noncontrolling Interests) | 912 |  |  | (10,274) |  |  | 8,340 |
Net earnings from continuing operations allocated to common stock for EPS calculation | $ | 314,214 |  |  | $ | 602,530 |  |  | $ | 387,465 |
Net (loss) earnings from discontinued operations allocated to common stock for EPS calculation | $ | (23,966) |  |  | $ | 193,289 |  |  | $ | 286,652 |
Net earnings allocated to common stock for EPS calculation | $ | 290,248 |  |  | $ | 795,819 |  |  | $ | 674,117 |
Denominator for Basic and Diluted EPS: |  |  |  |  |
Shares used for calculating basic EPS attributable to common stock | 121,468 |  |  | 125,324 |  |  | 126,607 |
Effect of dilutive securities: |  |  |  |  |
Stock compensation plans | 464 |  |  | 557 |  |  | 607 |
Shares used for calculating diluted EPS attributable to common stock | 121,932 |  |  | 125,881 |  |  | 127,214 |
Net Earnings Per Share: |  |  |  |  |
Basic Net Earnings from Continuing Operations Per Share | $ | 2.59 |  |  | $ | 4.81 |  |  | $ | 3.06 |
Basic Net (Loss) Earnings from Discontinued Operations Per Share | $ | (0.20) |  |  | $ | 1.54 |  |  | $ | 2.26 |
Basic Earnings Per Share: | $ | 2.39 |  |  | $ | 6.35 |  |  | $ | 5.32 |
Diluted Net Earnings from Continuing Operations Per Share | $ | 2.58 |  |  | $ | 4.79 |  |  | $ | 3.05 |
Diluted Net (Loss) Earnings from Discontinued Operations Per Share | $ | (0.20) |  |  | $ | 1.54 |  |  | $ | 2.25 |
Diluted Earnings Per Share: | $ | 2.38 |  |  | $ | 6.32 |  |  | $ | 5.30 |
Note: Earnings per share amounts may not add due to rounding
Share Repurchases On January 16, 2020, the Company's Board of Directors authorized a share repurchase program of up to $1.0 billion of the Company's common stock (the "2020 Repurchase Authorization"). The 2020 Repurchase Authorization expired on January 15, 2023. On January 25, 2023, the Company's Board of Directors authorized an incremental share repurchase program of up to $1.0 billion of the Company's common stock, which would expire on January 25, 2026 (the "2023 Repurchase Authorization"). By the end of the second fiscal quarter of 2025, the Company had repurchased the full amount of common stock authorized under the 2023 Repurchase Authorization. On January 30, 2025, the Company's Board of Directors authorized an incremental share repurchase program of up to $1.5 billion of the Company's common stock, to expire on January 30, 2028 (the "2025 Repurchase Authorization"). At September 26, 2025, the Company had $1.2 billion remaining under the 2025 Repurchase Authorization. The following table summarizes repurchase activity under the 2020 Repurchase Authorization during fiscal 2023 through expiration during the second fiscal quarter of 2023:
Amount Authorized (2020 Repurchase Authorization) |  | Average Price Per Share (1) |  | Shares Repurchased |  | Total Shares Retired |  |
$1,000,000,000 |  | $113.56 |  | 1,237,688 |  | 1,237,688 |  |
(1)Includes commissions paid and excise tax due under the Inflation Reduction Act of 2022 and calculated at the average price per share. The following table summarizes the activity under the 2023 Repurchase Authorization during fiscal 2025:
Amount Authorized (2023 Repurchase Authorization) |  | Average Price Per Share (1) |  | Shares Repurchased |  | Total Shares Retired
$1,000,000,000 |  | $133.51 |  | 3,570,275 |  | 3,570,275
(1)Includes commissions paid and excise tax due under the Inflation Reduction Act of 2022 and calculated at the average price per share. The following table summarizes the activity under the 2025 Repurchase Authorization during fiscal 2025:
Amount Authorized (2025 Repurchase Authorization) |  | Average Price Per Share (1) |  | Shares Repurchased |  | Total Shares Retired
$1,500,000,000 |  | $131.05 |  | 2,117,350 |  | 2,117,350
(1)Includes commissions paid and excise tax due under the Inflation Reduction Act of 2022 and calculated at the average price per share. Our share repurchase programs do not obligate the Company to purchase any shares. Share repurchases may be executed through various means including, without limitation, accelerated share repurchases, open market transactions, privately negotiated transactions, purchases pursuant to a Rule 10b5-1 plan or otherwise. The authorization for the share repurchase programs may be terminated, increased or decreased by the Company’s Board of Directors in its discretion at any time. The timing, amount and manner of share repurchases may depend upon market conditions and economic circumstances, availability of investment opportunities, the availability and costs of financing, currency fluctuations, the market price of the Company's common stock, other uses of capital and other factors. Common and Preferred Stock Jacobs is authorized to issue two classes of capital stock designated “common stock” and “preferred stock” (each has a par value of $1.00 per share). The preferred stock may be issued in one or more series. The number of shares to be included in a series as well as each series’ designation, relative powers, dividend and other preferences, rights and qualifications, redemption provisions and restrictions are to be fixed by the Company’s Board of Directors at the time each series is issued. Except as may be provided by the Company’s Board of Directors in a preferred stock designation, or otherwise provided for by statute, the holders of shares of common stock have the exclusive right to vote for the election of directors and on all other matters requiring stockholder action. The holders of shares of common stock are entitled to dividends if and when declared by the Company’s Board of Directors from whatever assets are legally available for that purpose. Dividends On November 18, 2025, the Company’s Board of Directors declared a quarterly dividend of $0.32 per share of the Company’s common stock, which will be paid on December 19, 2025, to shareholders of record on the close of business on December 2, 2025. Future dividend declarations are subject to review and approval by the Company’s Board of Directors. Dividends paid through September 26, 2025 and the preceding fiscal year are as follows:
Declaration Date |  | Record Date |  | Payment Date |  | Cash Amount (per share) |
July 31, 2025 |  | August 22, 2025 |  | September 19, 2025 |  | $0.32 |
April 30, 2025 |  | May 23, 2025 |  | June 20, 2025 |  | $0.32 |
January 30, 2025 |  | February 21, 2025 |  | March 21, 2025 |  | $0.32 |
September 26, 2024 |  | October 25, 2024 |  | November 22, 2024 |  | $0.29 |
July 11, 2024 |  | July 26, 2024 |  | August 23, 2024 |  | $0.29 |
May 2, 2024 |  | May 24, 2024 |  | June 21, 2024 |  | $0.29 |
January 25, 2024 |  | February 23, 2024 |  | March 22, 2024 |  | $0.29 |
September 28, 2023 |  | October 27, 2023 |  | November 9, 2023 |  | $0.26 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareReconciliationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration